Navigation Links
Strand Diagnostics appoints new President
Date:1/23/2013

INDIANAPOLIS, Jan. 23, 2013 /PRNewswire/ -- Strand Diagnostics, LLC, maker of the know error® system, announced today the appointment of Laura Beggrow as President. She was recruited by Strand Diagnostics to drive the sales and marketing efforts of the company.

(Logo: http://photos.prnewswire.com/prnh/20130109/NE31719LOGO )

"We are very excited about adding Laura to our team," said Strand Diagnostics CEO, Ted Schenberg . "We expect that her experience in building out large-scale sales organizations, and her track record of driving growth in early-stage molecular diagnostics companies will help accelerate adoption of the know error® system as the new standard of care."

Prior to joining Strand Diagnostics, Beggrow served as Vice President of U.S. Sales and Marketing at Genomic Health. During her tenure, she was responsible for commercializing the company's groundbreaking Oncotype DX products in the breast and colon cancer markets, growing sales of the Oncotype DX test from $10 million to more than $200 million per year.

"Laura's background is a perfect fit for where we are as a company," said Schenberg. "Her experience in commercializing molecular diagnostic testing for breast and prostate cancers will be a tremendous asset as we look to grow adoption of the know error® system."

"I am extremely excited to join Strand Diagnostics," said Beggrow. "They have developed some very compelling products in a short period of time and established a solid foundation on which to build. Specimen provenance is an under-appreciated aspect of the diagnostic cycle, with as many as 3.5 percent of biopsies in certain clinical settings resulting in a diagnosis complicated by undetected specimen switches or contaminations. The know error® system gives healthcare providers a tool to ensure that the right diagnosis is assigned to the right patient at the right time and the right cost – and all of this begins with the right specimen. I look forward to working with this talented and dedicated team to eliminate diagnostic mistakes due to undetected provenance errors."

The know error® system compares the DNA profile of a biopsy specimen to the DNA profile of a reference sample taken via cheek swab. This process safeguards patients from diagnostic and treatment errors that may occur due to undetected switches or contamination of biopsy specimens during the complex diagnostic testing cycle for cancer.

About Strand Diagnostics   
As a comprehensive provider of DNA testing services, Strand Diagnostics has a strong track record of using cutting-edge technology to solve complex problems in the criminal justice system and life sciences sector. The company's forensic division supports law enforcement agencies with forensic DNA identity testing services. Strand Diagnostics' healthcare division developed and markets the know error® system, which is used by physicians and laboratories to confirm specimen provenance as an integral component of the diagnostic testing cycle for cancer, ensuring patients are always matched with the appropriate diagnosis.

Contact: 
Mike Harmon  
Strand Diagnostics / Know Error   
888-9BIOPSY (924-6779) x114  
mharmon@knowerror.com   

Kirsten Fallon
Schwartz MSL     
781-684-0770        
knowerror@SchwartzMSL.com      


'/>"/>
SOURCE Strand Diagnostics, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Trovagene and Strand Life Sciences Agree to Validate and Commercialize Urine-Based HPV Test in India and South Asia
2. Isis Pharmaceuticals Demonstrates The Potential Of Single-Stranded RNA-Like Antisense Technology To Activate The RNAi Pathway
3. HOLOGIC ANNOUNCES ORGANIZATIONAL CHANGES TO ITS DIAGNOSTICS SEGMENT; INTEGRATION OF GEN-PROBE PROCEEDING AHEAD OF SCHEDULE
4. Johnson & Johnson Presents Growth Strategies for Medical Devices & Diagnostics Segment
5. Roche Diagnostics Named to FORTUNE magazines 2013 list of "100 Best Companies to Work For"
6. MGC Diagnostics Corporation Reports Fourth Quarter and Fiscal Year 2012 Operating Results
7. Cardiology Point of Care Diagnostics: Products, players & outlook to 2017
8. The Complete Guide to Companion Diagnostics: Market Environment Products and Companies
9. Increasing Prevalence of Heart Disease Drives Growth of Cardiac Biomarkers Diagnostics Market, Says Frost & Sullivan
10. MGC Diagnostics Corporation to Report Fourth Quarter and Fiscal Year 2012 Financial Results on Wednesday, December 19, 2012
11. Artemis Diagnostics awarded two grants from Technology Strategy Board to develop cancer imaging technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... PARIS , April 27, 2016 ... Year-Over-Year Including 42% Growth in Recurring Consumable Sales  ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) ... today announced its sales for the first quarter ended ... business and the execution of its commercial strategy. ...
(Date:4/27/2016)...   Zillion Group today announced the ... which specializes in live video consultation. Turning content, ... Zillion enables companies to realize the true potential ... control of their health. Zillion,s ... one-to-one, group and webcast scheduled or on-demand – ...
(Date:4/27/2016)... LEXINGTON, Massachusetts , April 27, 2016 ... announces that Jeff Poulton , Chief Financial Officer, will ... in Boston, MA on Wednesday, May ... live audio webcast will be available on the Presentations and ... Subsequently, a replay of the webcast will be available on ...
Breaking Medicine Technology:
(Date:5/2/2016)... ... 2016 , ... Pregnancy Awareness Month offers a great time to get familiar ... you are ready to have a baby, it’s best to get started before age ... your Personal Conception & Pregnancy Organizer, written for women who plan on becoming pregnant ...
(Date:5/2/2016)... ... May 02, 2016 , ... TeleMedCo™, a ... designed to automate and improve the rapid diagnosis, triage and admission of patients ... platform, application, and mobile experience for the first time at GENBAND’s Perspectives16 conference. ...
(Date:5/2/2016)... ... May 02, 2016 , ... ... EVP and GM Jim Callandrillo and Duane Reed, VP of business development ... Pharmaceutical Business Intelligence and Research Group (PBIRG) General Meeting from May 15-17 ...
(Date:5/2/2016)... ... May 02, 2016 , ... Atlantic Information Services, Inc. (AIS) is pleased to ... Could Transform the Pharma Landscape .” CMS recently proposed a test of alternate payment ... drugs while preserving care provided to beneficiaries. The webinar will review the details of ...
(Date:5/2/2016)... ... 2016 , ... For many artists, the act of blending paint is based ... a science. , Using the new, highly precise METTLER TOLEDO ML204T balance to ... and meaning to his works. What’s more, it has allowed him to recreate these ...
Breaking Medicine News(10 mins):